PET Study to Determine Muscarinic Receptor Occupancy in Lungs After Inhalation of AZD2115 and Tiotropium
Clinical trial NCT03097380 · COMPLETED
Trial details
- NCT number
- NCT03097380
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-26
- Primary completion
- 2017-12-30
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.